4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-24-047697
President & COO sold 100,000 shares at $11.32 ($1,132,000)
- President & COO acquired 100,000 shares (option exercise)
- President & COO gave up 10,945 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2024-11-20 | Shares withheld for taxes 10b5-1 | −10,945 | $11.49 | $125,758 | 606,525 | D |
| Venker Eric President & COO | 2024-11-20 | Option exercise 10b5-1 | +100,000 | $3.85 | $385,000 | 706,525 | D |
| Venker Eric President & COO | 2024-11-20 | Sale 10b5-1 | −100,000 | $11.32 | $1,132,000 | 606,525 | D |
| Derivatives | |||||||
| Venker Eric President & COO | 2024-11-20 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 12,326,234 | D | ||
| Open-market sales · 100,000 sh · avg $11.32 · $1,132,000 | |||||||
Loading xslF345X05/form4.xml…